These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 14733400)

  • 1. The cost and cost-effectiveness of PPIs--GP perspectives and responses to a prescribing dilemma and their implications for the development of patient-centred healthcare.
    Pollock K; Grime J
    Eur J Gen Pract; 2003 Dec; 9(4):126-33, 140. PubMed ID: 14733400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource.
    Pollock K; Grime J
    Soc Sci Med; 2000 Dec; 51(12):1827-39. PubMed ID: 11128270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors: perspectives of patients and their GPs.
    Grime J; Pollock K; Blenkinsopp A
    Br J Gen Pract; 2001 Sep; 51(470):703-11. PubMed ID: 11593830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing.
    Prosser H; Walley T
    Soc Sci Med; 2005 Mar; 60(6):1335-46. PubMed ID: 15626528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared care: a qualitative study of GPs' and hospital doctors' views on prescribing specialist medicines.
    Horne R; Mailey E; Frost S; Lea R
    Br J Gen Pract; 2001 Mar; 51(464):187-93. PubMed ID: 11255899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New medicines in primary care: a review of influences on general practitioner prescribing.
    Mason A
    J Clin Pharm Ther; 2008 Feb; 33(1):1-10. PubMed ID: 18211610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The compatibility of prescribing guidelines and the doctor-patient partnership: a primary care mixed-methods study.
    Solomon J; Raynor DK; Knapp P; Atkin K
    Br J Gen Pract; 2012 Apr; 62(597):e275-81. PubMed ID: 22520915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rise and rise of proton pump inhibitor drugs: patients' perspectives.
    Boath EH; Blenkinsopp A
    Soc Sci Med; 1997 Nov; 45(10):1571-9. PubMed ID: 9351147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of proton pump inhibitors: an exploration of the attitudes, knowledge and perceptions of general practitioners.
    Raghunath AS; Hungin AP; Cornford CS; Featherstone V
    Digestion; 2005; 72(4):212-8. PubMed ID: 16286734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why do GPs continue inappropriate hospital prescriptions of proton pump inhibitors? A qualitative study.
    Wermeling M; Himmel W; Behrens G; Ahrens D
    Eur J Gen Pract; 2014 Sep; 20(3):174-80. PubMed ID: 24219345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study.
    Watkins C; Timm A; Gooberman-Hill R; Harvey I; Haines A; Donovan J
    Fam Pract; 2004 Dec; 21(6):661-9. PubMed ID: 15528289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions of the impact of primary care organizations on GP prescribing: the iron fist in the velvet glove?
    Prosser H; Walley T
    J Health Organ Manag; 2007; 21(1):5-26. PubMed ID: 17455809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors: a study of GPs' prescribing.
    Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
    Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
    Targownik LE; Fisher DA; Saini SD
    Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost to the patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK-Italy comparison.
    Hassell K; Atella V; Schafheutle EI; Weiss MC; Noyce PR
    Eur J Public Health; 2003 Mar; 13(1):18-23. PubMed ID: 12678309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of factors associated with cost and variation in prescribing among GPs.
    Carthy P; Harvey I; Brawn R; Watkins C
    Fam Pract; 2000 Feb; 17(1):36-41. PubMed ID: 10673486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia.
    Wu J; Dickinson S; Elgebaly Z; Blogg S; Heaney A; Soo Y; Daniels B; Weekes L
    BMC Fam Pract; 2020 May; 21(1):85. PubMed ID: 32386520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
    Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
    J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "What lies beneath it all?"--an interview study of GPs' attitudes to the use of guidelines.
    Carlsen B; Norheim OF
    BMC Health Serv Res; 2008 Oct; 8():218. PubMed ID: 18945360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of the long-term use of proton pump inhibitors by a patient-oriented electronic decision support tool (arriba-PPI): study protocol for a randomized controlled trial.
    Rieckert A; Becker A; Donner-Banzhof N; Viniol A; Bücker B; Wilm S; Sönnichsen A; Barzel A
    Trials; 2019 Nov; 20(1):636. PubMed ID: 31752978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.